TG - thyroglobulin Gene
Species: Bos taurus
Gene Type: protein coding
Gene ID: 280706
TG Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_173883.2 | NP_776308.1 | thyroglobulin precursor |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
thyroglobulin |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(5)
| Cat. No. | 상품명 |
효과
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-10409 | Fedratinib | 99.87% | Yes | |
| HY-10409A | Fedratinib hydrochloride hydrate | 99.92% | Yes | |
| HY-B0747 | Eicosapentaenoic acid ethyl ester | 98.0% | Unkown | |
| HY-111023 | Nemonoxacin malate | Inhibitor | 99.29% | Unkown |
| HY-165090 | 1,3-Distearoyl-2-lauroyl glycerol | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(1)
| Cat. No. | 상품명 |
효과
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P99538 | Ublituximab | Inhibitor | 98.42% | Unkown |
Clinical Phase
Bioactive Molecules
(13)
| Cat. No. | 상품명 |
효과
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-165051 | 1,3-Dibutyryl-2-oleoyl glycerol | / | Phase 4 | |
| HY-165037 | 1,2-Dimyristoyl-3-eicosapentaenoyl-rac-glycerol | / | Phase 3 | |
| HY-19359 | Vilagletistat | Inhibitor | 99.97% | Phase 2 |
| HY-10111 | TG100-115 | Inhibitor | 99.41% | Phase 2 |
| HY-15163 | Zotiraciclib | Inhibitor | 99.88% | Phase 2 |
| HY-19867A | Burixafor hydrobromide | Antagonist | 99.70% | Phase 2 |
| HY-10186 | TG 100801 | Inhibitor | 98.61% | Phase 2 |
| HY-14783 | Apricoxib | Inhibitor | 98.84% | Phase 2 |
| HY-145522 | 13-Dimyristoyl-2-Eicosapentaenoyl Glycerol | / | Phase 2 | |
| HY-19867 | Burixafor | Antagonist | / | Phase 2 |
| HY-10187 | TG 100801 Hydrochloride | Inhibitor | / | Phase 2 |
| HY-P2962 | Transglutaminase, Streptoverticillium mobaraense | / | Phase 1 | |
| HY-123765 | JTT-553 | Inhibitor | / | Phase 1 |
Bioactive MoleculesInhibitory Antibodies
(4)
| Cat. No. | 상품명 |
효과
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-P99822 | Recaticimab | Inhibitor | 99.71% | Phase 4 |
| HY-P99833 | Cosibelimab | Inhibitor | 99.90% | Phase 3 |
| HY-P99512 | Zampilimab | Inhibitor | ≥99.0% | Phase 2 |
| HY-P990694 | Zeripatamig | Inhibitor | ≥99.0% | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(213)
| Cat. No. | 상품명 |
효과
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-112540B | Acetoacetic acid sodium | 98.0% | Unkown | |
| HY-15338 | TG003 | Inhibitor | 99.57% | Unkown |
| HY-112540A | Acetoacetic acid lithium | 98.0% | Unkown | |
| HY-153523 | Hi 76-0079 | Inhibitor | 99.87% | Unkown |
| HY-N2118 | Bilobetin | Activator | 99.71% | Unkown |
| HY-112540 | Acetoacetic acid | 95.0% | Unkown | |
| HY-15166 | (E/Z)-Zotiraciclib | Inhibitor | 99.96% | Unkown |
| HY-18971 | TG4-155 | Antagonist | 99.91% | Unkown |
| HY-117678 | TG-2-IN-1 | Inhibitor | 98.0% | Unkown |
| HY-W076543 | 5-(Biotinamido)pentylamine | 99.96% | Unkown | |
| HY-10410 | TG101209 | 98.81% | Unkown | |
| HY-110381 | JNJ-DGAT2-A | Inhibitor | 98.26% | Unkown |
| HY-123290 | KCC009 | Inhibitor | 98.06% | Unkown |
| HY-N2078 | Yamogenin | 99.86% | Unkown | |
| HY-W015600 | 2-Acetamidophenol | 99.73% | Unkown | |
| HY-16978 | TG6-10-1 | Antagonist | 99.50% | Unkown |
| HY-139362 | Enpp-1-IN-2 | Inhibitor | 99.51% | Unkown |
| HY-15166A | (E/Z)-Zotiraciclib hydrochloride | Inhibitor | 99.90% | Unkown |
| HY-146726S | Tripentadecanoin-d29 | 99.24% | Unkown | |
| HY-129126 | NC9 | Inhibitor | 99.98% | Unkown |
| HY-156010 | PPARγ-IN-2 | Inhibitor | 99.65% | Unkown |
| HY-158774 | TG2-179-1 | Inducer | 99.0% | Unkown |
| HY-10185 | TG 100572 Hydrochloride | Inhibitor | 98.76% | Unkown |
| HY-145933 | BJJF078 | Inhibitor | 99.66% | Unkown |
| HY-164049 | TG8-260 | Antagonist | 99.13% | Unkown |
| HY-122631 | TG693 | 99.95% | Unkown | |
| HY-B1434 | 7-Aminocephalosporanic acid | Inhibitor | 98.0% | Unkown |
| HY-N0368R | Linalool (Standard) | 97.16% | Unkown | |
| HY-114994 | MS437 | Activator | 98.0% | Unkown |
| HY-122709 | TG2 inhibitor VA4 | Inhibitor | 99.66% | Unkown |
| HY-15166B | (E/Z)-Zotiraciclib citrate | Inhibitor | 99.83% | Unkown |
| HY-172089 | TG101209 analog 1 | Inducer | 98.27% | Unkown |
| HY-W674124 | Tripentadecanoin | 98.0% | Unkown | |
| HY-128595 | MT-4 | Inhibitor | 99.84% | Unkown |
| HY-W012802 | Methyl 1H-pyrrole-2-carboxylate | 99.98% | Unkown | |
| HY-137438 | Edralbrutinib | Inhibitor | 99.75% | Unkown |
| HY-13514 | TG 100713 | Inhibitor | 99.21% | Unkown |
| HY-146914S | 16:0-18:0-16:0 TG-d5 | 99.90% | Unkown | |
| HY-14956 | Nemonoxacin | Inhibitor | 99.77% | Unkown |
| HY-155102 | PROTAC TG2 degrader-2 | Degrader | 99.15% | Unkown |
| HY-N0368S | Linalool-d3 | 95.17% | Unkown | |
| HY-W015600S | 2-Acetamidophenol-d3 | 99.48% | Unkown | |
| HY-102073 | TG53 | Inhibitor | 98.6% | Unkown |
| HY-14956S | Nemonoxacin-d3 | Inhibitor | 99.93% | Unkown |
| HY-161939 | 7030B-C5 | Inhibitor | 99.78% | Unkown |
| HY-162141 | MD102 | 98.01% | Unkown | |
| HY-177133 | Suvigletistat | Inhibitor | 99.82% | Unkown |
| HY-P1822 | BDC2.5 mimotope 1040-31 | Agonist | 99.75% | Unkown |
| HY-165041 | 1,3-Dioleoyl-2-stearoyl glycerol | 99.9% | Unkown | |
| HY-172083 | 15:0-18:1-15:0 TG | 99.0% | Unkown | |
| HY-W704600 | 1,3-Distearoyl-2-oleoyl glycerol | 98.10% | Unkown | |
| HY-146913S | 15:0-18:1-15:0 TG-d5 | / | Unkown | |
| HY-146917S | 20:0-20:1-20:0 TG-d5 | 99.90% | Unkown | |
| HY-15338A | (E/Z)-TG003 | Inhibitor | 99.9% | Unkown |
| HY-158614 | 1-Palmitoyl-2-12-PAHSA-3-oleoyl-sn-glycerol | 99.9% | Unkown | |
| HY-158763A | MPI8 TFA | Inhibitor | / | Unkown |
| HY-163164S | 18:1-17:1-18:1 TG-d5 | 99.00% | Unkown | |
| HY-165046 | 1,2,3-Trilinoelaidoyl glycerol | Inhibitor | 98.0% | Unkown |
| HY-165054 | 1-Palmitoyl-2-stearoyl-3-oleoyl-rac-glycerol | 99.9% | Unkown | |
| HY-E70575 | Endonuclease VIII | / | Unkown | |
| HY-N7907 | Myricetin-3-O-β-D-xylopyranosyl-(1→2)-β-D-glucopyranoside | 99.12% | Unkown | |
| HY-10184 | TG 100572 | Inhibitor | / | Unkown |
| HY-146799S | 15:0-18:1-15:0 TG-d7 | 99.0% | Unkown | |
| HY-160132 | TG-2-IN-4 | Inhibitor | 99.62% | Unkown |
| HY-163163S | 18:1-21:2-18:1 TG-d5 | 99.00% | Unkown | |
| HY-165091 | 1,2-Dioctanoyl-3-decanoyl-rac-glycerol | 99.0% | Unkown | |
| HY-165426 | HB-230 | / | Unkown | |
| HY-N11286 | Tridocosahexaenoylglycerol | 98.7% | Unkown | |
| HY-W010667 | (Z)-2-(Oleoyloxy)propane-1,3-diyl dipalmitate | 98.01% | Unkown | |
| HY-W587772 | Mono(2-ethyl-5-hydroxyhexyl) terephthalate | 98.27% | Unkown | |
| HY-W923355 | 1,2,3-Trieicosapentaenoyl glycerol | 99.9% | Unkown | |
| HY-10104 | GRL-8234 | Inhibitor | / | Unkown |
| HY-103537A | BIIB042 | Modulator | / | Unkown |
| HY-10409S | Fedratinib-d9 | / | Unkown | |
| HY-111298 | TG 41 | Modulator | / | Unkown |
| HY-115705S | 1,2,3-Tri-10(Z)-Heptadecenoyl Glycerol-d5 | / | Unkown | |
| HY-116845 | TG3-95-1 | / | Unkown | |
| HY-118243 | KMS88009 | Inhibitor | / | Unkown |
| HY-119316 | CM-414 | Inhibitor | / | Unkown |
| HY-125958 | AA9 | Inhibitor | / | Unkown |
| HY-146398 | AMPK activator 6 | Activator | / | Unkown |
| HY-146737S | Tripentadecanoin-d5 | / | Unkown | |
| HY-146912S | 14:0-16:1-14:0 TG-d5 | / | Unkown | |
| HY-146916S | 19:0-12:0-19:0 TG-d5 | 99.0% | Unkown | |
| HY-149257 | HAT-SIL-TG-1&AT | Inhibitor | / | Unkown |
| HY-14956S1 | Nemonoxacin-d3-1 | Inhibitor | / | Unkown |
| HY-14956S2 | Nemonoxacin-d4 | Inhibitor | / | Unkown |
| HY-14956S3 | Nemonoxacin-13C,d3 | Inhibitor | / | Unkown |
| HY-14956S4 | Nemonoxacin-13C,d3 dihydrochloride | Inhibitor | / | Unkown |
| HY-151997S | 1,2-Dioleoyl-3-lauroyl-rac-glycerol-13C3 | / | Unkown | |
| HY-155643 | PROTAC TG2 degrader-1 | Inhibitor | / | Unkown |
| HY-157254 | AA10 | Inhibitor | / | Unkown |
| HY-157975 | LM11 | Inhibitor | / | Unkown |
| HY-158659 | TG11-77 hydrochloride | Antagonist | / | Unkown |
| HY-158749 | 1-Oleoyl-2-lauroyl-3-palmitoyl-rac-glycerol | / | Unkown | |
| HY-161985 | PPARγ-IN-3 | Inhibitor | / | Unkown |
| HY-163165S | 16:0-19:2-16:0 TG-d5 | / | Unkown | |
| HY-163345 | 5-HT7R antagonist 2 | Antagonist | / | Unkown |
| HY-165038 | 1,2-Didecanoyl-3-stearoyl-rac-glycerol | / | Unkown | |
| HY-165039 | 1,3-Dioleoyl-2-octanoyl glycerol | / | Unkown | |
| HY-165049 | 1-Stearoyl-2-oleoyl-3-linoleoyl-rac-glycerol | Substrate | / | Unkown |
| HY-165050 | 1,3-Dilinoleoyl-2-stearoyl glycerol | / | Unkown | |
| HY-165053 | 1,3-Distearoyl-2-palmitoyl glycerol | / | Unkown | |
| HY-165089 | 1,2-Dioleoyl-3-lauroyl-rac-glycerol | / | Unkown | |
| HY-165094 | 1-Myristoyl-2-linoleoyl-3-palmitoyl-rac-glycerol | / | Unkown | |
| HY-165106 | 1,2-Dibutyryl-3-palmitoyl-rac-glycerol | / | Unkown | |
| HY-165108 | 1,2-Dilinoleoyl-3-α-linolenoyl-rac-glycerol | / | Unkown | |
| HY-165109 | 1,3-Dioleoyl-2-lauroyl glycerol | / | Unkown | |
| HY-165110 | 1-Stearoyl-2-palmitoyl-3-oleoyl-rac-glycerol | / | Unkown | |
| HY-165111 | 1,2-Dioleoyl-3-myristoyl-rac-glycerol | / | Unkown | |
| HY-165112 | 1,2-Dioleoyl-3-α-linolenoyl-rac-glycerol | / | Unkown | |
| HY-165113 | 1,2-Distearoyl-3-arachidoyl-rac-glycerol | / | Unkown | |
| HY-173545 | 1-Palmitoyl-2-10-oahsa-3-oleoyl-sn-glycerol | / | Unkown | |
| HY-173546 | 1-Palmitoyl-2-12-oahsa-3-oleoyl-sn-glycerol | / | Unkown | |
| HY-173547 | 1-Palmitoyl-2-9-pahsa-3-oleoyl-sn-glycerol | / | Unkown | |
| HY-173548 | 1-Palmitoyl-2-10-pahsa-3-oleoyl-sn-glycerol | / | Unkown | |
| HY-176271 | MAO-B-IN-45 | / | Unkown | |
| HY-176751 | TG-2-IN-5 | Inhibitor | / | Unkown |
| HY-176817 | GPR109 receptor agonist-3 | Agonist | / | Unkown |
| HY-176981 | TG (18:2_20:3_20:4) | / | Unkown | |
| HY-176982 | TG (16:0_16:1_20:4) | / | Unkown | |
| HY-176983 | TG (16:0_18:2_20:4) | / | Unkown | |
| HY-176984 | TG (18:0_18:2_20:4) | / | Unkown | |
| HY-176985 | TG (18:1_20:2_20:4) | / | Unkown | |
| HY-176986 | TG (16:0_18:1_20:4) | / | Unkown | |
| HY-176987 | TG (18:0_18:1_20:4) | / | Unkown | |
| HY-176988 | TG (18:0_20:1_20:4) | / | Unkown | |
| HY-176989 | TG (16:0_16:0_20:4) | / | Unkown | |
| HY-178015 | THR-β agonist 11 | Agonist | / | Unkown |
| HY-180322 | TG2-IN-3h | Inhibitor | / | Unkown |
| HY-181457 | 1-Palmitoyl-2-9-OAHSA-3-oleoyl-sn-glycerol | / | Unkown | |
| HY-181634S | 16:0-15:1-16:0 TG-d5 | / | Unkown | |
| HY-181709 | TPM003 | Agonist | / | Unkown |
| HY-181732 | PROTAC TG2 Degrader-3 | / | Unkown | |
| HY-181737 | E3 Ligase Ligand-linker Conjugate 225 | / | Unkown | |
| HY-182325 | DB-310 | Inhibitor | / | Unkown |
| HY-182544S | 14:0-13:0-14:0 TG-d5 | / | Unkown | |
| HY-182545S | 14:0-15:1-14:0 TG-d5 | / | Unkown | |
| HY-182554S | 14:0-17:1-14:0 TG-d5 | / | Unkown | |
| HY-182556S | 16:0-17:1-16:0 TG-d5 | / | Unkown | |
| HY-183737 | ATG5/TECAIR-IN-1 | Inhibitor | / | Unkown |
| HY-18970 | TG6-129 | Antagonist | / | Unkown |
| HY-D1545 | Violamine R | / | Unkown | |
| HY-E70436 | Human keratinocyte transglutaminase | / | Unkown | |
| HY-E70437 | Guinea pig liver transglutaminase | / | Unkown | |
| HY-E70439 | Human epidermal transglutaminase | / | Unkown | |
| HY-E70453 | Human prostate transglutaminase | / | Unkown | |
| HY-E70454 | Human neuronal transglutaminase | / | Unkown | |
| HY-N11551 | Salvifaricin | / | Unkown | |
| HY-N12249 | 7-Deoxy-trans-dihydronarciclasine | Inhibitor | / | Unkown |
| HY-N15859 | 16:0-LR/18:1/18:1 TG - Lissamine rhodamine | / | Unkown | |
| HY-N15874 | C16/C11-TF/C12-DNP TG | / | Unkown | |
| HY-N15876 | 18:1-6:0 DNP-C11 BODIPY 505/515 TG | / | Unkown | |
| HY-N15883 | 18:1-C11 BODIPY 505/515-C11 BODIPY 505/515 TG | / | Unkown | |
| HY-N8214 | Isorhamnetin 3-O-β-D-glucose-7-O-β-D-gentiobioside | / | Unkown | |
| HY-NP222 | TG Protein, human | / | Unkown | |
| HY-P10677 | HB-3-20 | Degrader | / | Unkown |
| HY-P11348 | TG-MMP-Lys | Substrate | / | Unkown |
| HY-P11349 | TG-Gln | / | Unkown | |
| HY-P1822A | BDC2.5 mimotope 1040-31 TFA | Inhibitor | / | Unkown |
| HY-RS14432 | TG Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W423707 | TG 100948 | Inhibitor | / | Unkown |
| HY-115705 | 1,2,3-Tri-10(Z)-heptadecenoyl glycerol | / | Unkown | |
| HY-117110 | Arginylproline | / | Unkown | |
| HY-122989 | Aristolactam BIII | Inhibitor | / | Unkown |
| HY-125830 | ITIC | / | Unkown | |
| HY-142971 | 1-Myristoyl-2-Linoleoyl-3-Oleoyl-rac-glycerol | / | Unkown | |
| HY-142974 | 1,2-Dioleoyl-3-Docosohexaenoyl-rac-glycerol | / | Unkown | |
| HY-146915S | 17:0-17:1-17:0 TG-d5 | 99.90% | Unkown | |
| HY-158763 | MPI8 | Inhibitor | / | Unkown |
| HY-158945 | 1,3-Dipalmitoleoyl-2-11(Z)-octadecenoyl glycerol | / | Unkown | |
| HY-158946 | 1,2-Dielaidoyl-3-linoleoyl-rac-glycerol | / | Unkown | |
| HY-158948 | 1-Palmitoyl-2-11(Z)-octadecenoyl-3-butyroyl-rac-glycerol | / | Unkown | |
| HY-158949 | 1-Palmitoyl-2-11(Z)-octadecenoyl-3-oleoyl-rac-glycerol | / | Unkown | |
| HY-158957 | 1,3-Diheptadecanoyl-2-oleoyl glycerol | / | Unkown | |
| HY-158959 | 1,3-Diarachidonoyl-2-oleoyl glycerol | / | Unkown | |
| HY-158960 | 1,2-Dioleoyl-3-arachidonoyl-rac-glycerol | / | Unkown | |
| HY-158961 | 1,3-Dielaidoyl-2-oleoyl glycerol | / | Unkown | |
| HY-158962 | 1-Octanoyl-2-decanoyl-3-stearoyl-rac-glycerol | / | Unkown | |
| HY-158963 | 1,3-Dipalmitoyl-2-octanoyl glycerol | / | Unkown | |
| HY-158964 | 1-Palmitoyl-2-oleoyl-3-linolenoyl-rac-glycerol | / | Unkown | |
| HY-160984 | Rotraxate | / | Unkown | |
| HY-16266 | JNJ-DGAT1-A | Inhibitor | / | Unkown |
| HY-163166S | 18:1-19:2-18:1 TG-d5 | / | Unkown | |
| HY-165036 | 1,2-Dieicosapentaenoyl-3-palmitoyl-rac-glycerol | / | Unkown | |
| HY-165042 | 1,2-Dipalmitoyl-3-decanoyl-rac-glycerol | / | Unkown | |
| HY-165047 | 1-Palmitoyl-2-linoleoyl-3-stearoyl-rac-glycerol | / | Unkown | |
| HY-165048 | 1,3-Distearoyl-2-linoleoyl glycerol | / | Unkown | |
| HY-165052 | 1,3-Didocosahexaenoyl-2-palmitoyl glycerol | / | Unkown | |
| HY-165055 | 1-Oleoyl-2-palmitoyl-3-linoleoyl-rac-glycerol | / | Unkown | |
| HY-165056 | 1,2-Dipalmitoyl-3-linoleoyl-rac-glycerol | / | Unkown | |
| HY-165092 | 1-Arachidoyl-2-palmitoyl-3-oleoyl-rac-glycerol | / | Unkown | |
| HY-165093 | 1-Arachidoyl-2-oleoyl-3-palmitoyl-rac-glycerol | / | Unkown | |
| HY-165095 | 1,2-Dipalmitoleoyl-3-palmitoyl-rac-glycerol | / | Unkown | |
| HY-165105 | 1,3-Dioleoyl-2-decanoyl glycerol | / | Unkown | |
| HY-165107 | 1,2-Dioctanoyl-3-stearoyl-rac-glycerol | / | Unkown | |
| HY-165115 | 1,2-Dipalmitoyl-3-pentadecanoyl-rac-glycerol | / | Unkown | |
| HY-169473 | 1,2,3-Tri-13(E)-docosenoyl glycerol | 99.9% | Unkown | |
| HY-170465 | 1,2-Distearoyl-3-butyryl-glycerol | / | Unkown | |
| HY-170469 | 1,2-Dioleoyl-3-caprin | / | Unkown | |
| HY-171217 | TG-100435 | Inhibitor | / | Unkown |
| HY-173148 | TKB272 | Inhibitor | / | Unkown |
| HY-175648 | Antiparasitic agent-28 | Inhibitor | / | Unkown |
| HY-175725 | NR4A1 agonist 1 | Agonist | / | Unkown |
| HY-18112 | AZ-4217 | Inhibitor | / | Unkown |
| HY-N15875 | 18:1-18:1-C11 BODIPY 505/515 TG | / | Unkown | |
| HY-N8353 | Stachybotramide | / | Unkown | |
| HY-RS16550 | Tg Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS21232 | Cacna1a Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS22983 | Tg Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W643167 | 1,2,3-Tritridecanoylglycerol | 99.97% | Unkown | |
| HY-W710440 | 1,2-Distearoyl-3-palmitoyl-rac-glycerol | / | Unkown | |
| HY-W710512 | Propane-1,2,3-triyl tritricosanoate-d5 | / | Unkown |
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Homo sapiens | TG | NCBI | NCBI:7038 |
| Canis familiaris | TG | NCBI | NCBI:482047 |
| Macaca fascicularis | TG | NCBI | NCBI:102121703 |
| Mus musculus | TG | NCBI | NCBI:21819 |
| Susscrofa domestica | TG | NCBI | |
| Rattus norvegicus | TG | NCBI | NCBI:24826 |
| Macaca mulatta | TG | NCBI | NCBI:701756 |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service